November 1, 2016
Pfizer to discontinue two ongoing cardiovascular studies
Pfizer announced today the discontinuation of the global clinical development program for bococizumab…
Pharmaceuticals, Biotechnology and Life Sciences
Author: Dino Mustafić
November 1, 2016
Allergan closes down Tobira purchace
Allergan has completed the acquisition of Tobira Therapeutics
November 1, 2016
Novartis gets FDA Priority Review for first-line treatment of advanced breast cancer
Novartis gets FDA Priority Review for first-line treatment of HR+/HER2-advanced breast cancer
November 1, 2016
USFDA opens door to $30M market for India’s Strides Shasun’s HIV-1 infection tablets
India’s Strides Shasun Limited has received approval from the USFDA for Abacavir Tablets
November 1, 2016
Avacta’s Affimer molecules can be used as therapeutics
Avacta Group will present detailed data from the first pre-clinical in-vivo studies of its therapeutic Affimer platform
November 1, 2016
Advanced Oncotherapy sees board changes
Advanced Oncotherapy has announced that Lord David Evans has stepped down
October 31, 2016
New way to replace aortic valve successful in high-risk patients
New way to to perform transcatheter aortic valve replacemen successful in high-risk patients
October 31, 2016
French Genfit raises €78.5M, aims to invest in R&D
French Genfit has raised €78.5 million and invests in its R&D
October 31, 2016
Exclusive: EpiPen price hikes add millions to Pentagon costs
Mylan NV’s price hikes on EpiPens have added millions to U.S. Department of Defense spending…
October 31, 2016
FDA gives de novo approval for BD’s vaginitis detector
BD has gotten FDA market authorization for a first-of-its-kind molecular test…